Akso Health Group Past Earnings Performance
Past criteria checks 0/6
Akso Health Group has been growing earnings at an average annual rate of 29%, while the Healthcare industry saw earnings growing at 7.2% annually. Revenues have been growing at an average rate of 15.4% per year.
Key information
29.0%
Earnings growth rate
36.0%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | 15.4% |
| Return on equity | -6.6% |
| Net Margin | -375.2% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Akso Health Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 2 | -9 | 9 | 0 |
| 31 Dec 23 | 2 | -13 | 13 | 0 |
| 30 Sep 23 | 2 | -18 | 17 | 0 |
| 30 Jun 23 | 8 | -16 | 16 | 0 |
| 31 Mar 23 | 13 | -13 | 16 | 0 |
| 30 Sep 22 | 18 | 6 | -4 | 0 |
| 30 Jun 22 | 12 | 1 | 0 | 0 |
| 31 Mar 22 | 6 | -4 | 3 | 0 |
| 31 Dec 21 | 3 | -20 | 22 | 0 |
| 30 Sep 21 | 1 | -23 | 33 | 0 |
| 30 Jun 21 | 1 | -27 | 31 | 0 |
| 31 Mar 21 | 0 | -4 | 2 | 0 |
| 31 Dec 20 | -2 | -31 | 4 | 0 |
| 30 Sep 20 | 8 | -88 | 48 | 0 |
| 30 Jun 20 | 7 | -73 | 38 | 0 |
| 31 Mar 20 | 7 | -47 | 23 | 0 |
| 31 Dec 19 | -43 | -51 | -3 | 0 |
| 30 Sep 19 | 16 | -24 | 46 | 0 |
| 30 Jun 19 | 15 | -31 | 53 | 0 |
| 31 Mar 19 | 4 | -8 | 11 | 0 |
| 31 Dec 18 | 85 | 20 | 58 | 0 |
| 30 Sep 18 | 126 | 56 | 57 | 0 |
| 30 Jun 18 | 144 | 86 | 42 | 0 |
| 31 Mar 18 | 107 | 65 | 31 | 0 |
| 31 Dec 17 | 87 | 53 | 27 | 0 |
| 30 Sep 17 | 50 | 27 | 19 | 0 |
| 30 Jun 17 | 34 | 16 | 15 | 0 |
| 31 Mar 17 | 23 | 9 | 13 | 0 |
| 31 Dec 16 | 19 | 6 | 11 | 0 |
| 30 Sep 16 | 17 | 6 | 10 | 0 |
| 30 Jun 16 | 14 | 5 | 9 | 0 |
| 31 Mar 16 | 12 | 4 | 8 | 0 |
| 31 Mar 15 | 5 | 0 | 5 | 0 |
Quality Earnings: 8HX is currently unprofitable.
Growing Profit Margin: 8HX is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 8HX is unprofitable, but has reduced losses over the past 5 years at a rate of 29% per year.
Accelerating Growth: Unable to compare 8HX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 8HX is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (40.5%).
Return on Equity
High ROE: 8HX has a negative Return on Equity (-6.59%), as it is currently unprofitable.